• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体切除术联合局部视网膜激光光凝治疗特发性黄斑毛细血管扩张症

Pars plana vitrectomy combined with focal endolaser photocoagulation for idiopathic macular telangiectasia.

作者信息

Terauchi Gaku, Matsumoto Celso Soiti, Shinoda Kei, Matsumoto Harue, Imamura Yutaka, Watanabe Emiko, Kondo Takaaki, Mizota Atsushi

机构信息

Department of Ophthalmology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-0003, Japan.

Department of Ophthalmology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-0003, Japan ; Matsumoto Eye Clinic, Tokushima 771-1705, Japan.

出版信息

Case Rep Med. 2014;2014:786578. doi: 10.1155/2014/786578. Epub 2014 Apr 30.

DOI:10.1155/2014/786578
PMID:24876845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4021993/
Abstract

Background. To report the outcome of pars plana vitrectomy (PPV) combined with intraoperative endolaser focal photocoagulation (PC) on eyes with idiopathic macular telangiectasis (MacTel) type 1. Methods. This was a retrospective study of two female patients with MacTel type 1 who were resistant to focal photocoagulation, sub-Tenon triamcinolone injection, and/or antiangiogenic drugs. The best-corrected visual acuity (BCVA) was determined, and fluorescein angiography (FA) and spectral domain optical coherence tomography (SD-OCT) were performed before and after surgery for up to 19 months. Results. After surgery, the BCVA gradually improved from 20/100 to 20/20 at 19 months in Case 1 and from 20/50 to 20/13 at 13 months in Case 2. Fluorescein angiography (FA) showed leakage at the late phase, and OCT showed that the cystoid macular edema was resolved and the fovea was considerably thinner postoperatively. Conclusion. Patients with MacTel type 1 who are refractory to the other types of treatments can benefit from PPV combined with intraoperative endolaser focal PC with functional and morphological improvements.

摘要

背景。报告玻璃体切除术(PPV)联合术中激光聚焦光凝(PC)治疗1型特发性黄斑毛细血管扩张症(MacTel)患者的疗效。方法。这是一项回顾性研究,研究对象为两名对局部光凝、球后注射曲安奈德和/或抗血管生成药物治疗无效的1型MacTel女性患者。测定最佳矫正视力(BCVA),并在手术前后进行长达19个月的荧光素血管造影(FA)和光谱域光学相干断层扫描(SD-OCT)。结果。术后,病例1的BCVA在19个月时从20/100逐渐提高到20/20,病例2的BCVA在13个月时从20/50提高到20/13。荧光素血管造影(FA)显示晚期渗漏,OCT显示术后黄斑囊样水肿消退,黄斑中心凹明显变薄。结论。对其他类型治疗无效的1型MacTel患者可从PPV联合术中激光聚焦PC中获益,功能和形态均有改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e754/4021993/04393b280aee/CRIM2014-786578.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e754/4021993/e6d32d18db9b/CRIM2014-786578.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e754/4021993/104f4cafec76/CRIM2014-786578.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e754/4021993/f25f87dfe4e4/CRIM2014-786578.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e754/4021993/97105c244896/CRIM2014-786578.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e754/4021993/04393b280aee/CRIM2014-786578.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e754/4021993/e6d32d18db9b/CRIM2014-786578.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e754/4021993/104f4cafec76/CRIM2014-786578.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e754/4021993/f25f87dfe4e4/CRIM2014-786578.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e754/4021993/97105c244896/CRIM2014-786578.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e754/4021993/04393b280aee/CRIM2014-786578.005.jpg

相似文献

1
Pars plana vitrectomy combined with focal endolaser photocoagulation for idiopathic macular telangiectasia.玻璃体切除术联合局部视网膜激光光凝治疗特发性黄斑毛细血管扩张症
Case Rep Med. 2014;2014:786578. doi: 10.1155/2014/786578. Epub 2014 Apr 30.
2
Outcomes of Pars Plana Vitrectomy with Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy Without Retinal Detachment: A Seven-Year Retrospective Study.不伴有视网膜脱离的增生性糖尿病视网膜病变行玻璃体切割联合全视网膜光凝术的疗效:一项七年回顾性研究
Clin Ophthalmol. 2023 Feb 1;17:471-478. doi: 10.2147/OPTH.S400474. eCollection 2023.
3
Comparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia.非增生型 2 型特发性黄斑毛细血管扩张症的观察、玻璃体内注射贝伐单抗与经平坦部玻璃体切除术的比较。
Graefes Arch Clin Exp Ophthalmol. 2013 Apr;251(4):1097-101. doi: 10.1007/s00417-012-2150-1. Epub 2012 Sep 6.
4
Management of idiopathic retinal vasoproliferative tumors by slit-lamp laser or endolaser photocoagulation.经裂隙灯激光或眼内激光光凝治疗特发性视网膜血管性肿瘤的管理。
Am J Ophthalmol. 2014 Jul;158(1):154-161.e1. doi: 10.1016/j.ajo.2014.03.005. Epub 2014 Mar 12.
5
Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.糖尿病性黄斑水肿玻璃体切除术后早期视网膜厚度变化及并发症
Am J Ophthalmol. 2003 Jan;135(1):14-9. doi: 10.1016/s0002-9394(02)01819-6.
6
Indocyanine green angiography-guided laser photocoagulation combined with sub-Tenon's capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia.吲哚菁绿血管造影引导下激光光凝联合曲安奈德经Tenon 囊下注射治疗特发性黄斑毛细血管扩张症。
Br J Ophthalmol. 2010 May;94(5):600-5. doi: 10.1136/bjo.2009.163790. Epub 2009 Oct 21.
7
Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion.玻璃体切割术、内界膜剥除术及全视网膜光凝术治疗视网膜中央静脉阻塞继发的黄斑水肿
Am J Ophthalmol. 2009 Apr;147(4):627-633.e1. doi: 10.1016/j.ajo.2008.10.024. Epub 2009 Feb 4.
8
[Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].联合药物手术治疗糖尿病性黄斑水肿:核心玻璃体切除术联合玻璃体内注射贝伐单抗和曲安奈德
Klin Monbl Augenheilkd. 2011 Oct;228(10):910-4. doi: 10.1055/s-0029-1245965. Epub 2011 Oct 13.
9
LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2.玻璃体内注射贝伐单抗治疗继发于2型特发性黄斑毛细血管扩张症的视网膜下新生血管的长期预后
Retina. 2016 Nov;36(11):2150-2157. doi: 10.1097/IAE.0000000000001035.
10
Pars plana vitrectomy with internal limiting membrane peeling for refractory diffuse diabetic macular edema.玻璃体切割联合内界膜剥除术治疗难治性弥漫性糖尿病性黄斑水肿
J Ophthalmic Vis Res. 2010 Jul;5(3):162-7.

引用本文的文献

1
Comparison of anatomical and visual outcomes following different anti-vascular endothelial growth factor treatments in subretinal neovascular membrane secondary to type 2 proliferative macular telangiectasia.2 型增殖性黄斑毛细血管扩张症继发视网膜下新生血管膜的不同抗血管内皮生长因子治疗后解剖和视力结果的比较。
Graefes Arch Clin Exp Ophthalmol. 2020 Jan;258(1):99-106. doi: 10.1007/s00417-019-04520-x. Epub 2019 Nov 25.
2
Widening use of dexamethasone implant for the treatment of macular edema.地塞米松植入物在黄斑水肿治疗中的应用日益广泛。
Drug Des Devel Ther. 2017 Aug 16;11:2359-2372. doi: 10.2147/DDDT.S138922. eCollection 2017.

本文引用的文献

1
Intravitreal ranibizumab and laser photocoagulation in the management of idiopathic juxtafoveolar retinal telangiectasia type 1: a case report.玻璃体内注射雷珠单抗联合激光光凝治疗1型特发性黄斑旁视网膜毛细血管扩张症:病例报告
Case Rep Ophthalmol. 2012 Sep;3(3):298-303. doi: 10.1159/000342848. Epub 2012 Sep 12.
2
Comparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia.非增生型 2 型特发性黄斑毛细血管扩张症的观察、玻璃体内注射贝伐单抗与经平坦部玻璃体切除术的比较。
Graefes Arch Clin Exp Ophthalmol. 2013 Apr;251(4):1097-101. doi: 10.1007/s00417-012-2150-1. Epub 2012 Sep 6.
3
Use of intravitreal bevacizumab injections to treat type 1 idiopathic macular telangiectasia.
玻璃体内注射贝伐单抗治疗1型特发性黄斑毛细血管扩张症。
Graefes Arch Clin Exp Ophthalmol. 2012 Nov;250(11):1697-9. doi: 10.1007/s00417-011-1798-2. Epub 2011 Aug 24.
4
Indocyanine green angiography-guided laser photocoagulation combined with sub-Tenon's capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia.吲哚菁绿血管造影引导下激光光凝联合曲安奈德经Tenon 囊下注射治疗特发性黄斑毛细血管扩张症。
Br J Ophthalmol. 2010 May;94(5):600-5. doi: 10.1136/bjo.2009.163790. Epub 2009 Oct 21.
5
Bevacizumab in the treatment of idiopathic macular telangiectasia.贝伐单抗治疗特发性黄斑毛细血管扩张症
Graefes Arch Clin Exp Ophthalmol. 2008 Aug;246(8):1189-93. doi: 10.1007/s00417-008-0795-6. Epub 2008 Apr 2.
6
Idiopathic macular telangiectasia.特发性黄斑毛细血管扩张症
Arch Ophthalmol. 2006 Apr;124(4):450-60. doi: 10.1001/archopht.124.4.450.
7
Use of intravitreal triamcinolone acetonide injection in unilateral idiopathic juxtafoveal telangiectasis.玻璃体内注射曲安奈德治疗单侧特发性黄斑旁毛细血管扩张症
Clin Exp Ophthalmol. 2005 Oct;33(5):542-4. doi: 10.1111/j.1442-9071.2005.01081.x.
8
Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases.视网膜静脉阻塞性黄斑水肿减压的内界膜剥除术:14例报告
Retina. 2004 Jun;24(3):348-55. doi: 10.1097/00006982-200406000-00002.
9
Intravitreal triamcinolone acetonide for bilateral acquired parafoveal telangiectasis.玻璃体内注射曲安奈德治疗双侧获得性黄斑旁毛细血管扩张症。
Arch Ophthalmol. 2003 Nov;121(11):1658-9. doi: 10.1001/archopht.121.11.1658.
10
Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion.视网膜分支静脉阻塞的玻璃体切除术联合动静脉减压及内界膜剥除术
Retina. 2002 Dec;22(6):740-6. doi: 10.1097/00006982-200212000-00009.